Scribd Logo
Upload

Welcome to Scribd!

  • Chinese Biopharma-Mckinsey Report

    Uploaded by

    PHILCARE PHARMA
    17 views18 pages
    The document discusses the rise of China's biopharmaceutical industry. It notes that China now has over 4,000 biopharma companies and produces over 200 biologics. However, China still lags Western countries in terms of innovation. The government is investing heavily in R&D and talent to try to close this gap and become a global biopharma leader. The future of China's industry remains uncertain but it aims to have at least 5 homegrown biologics approved by 2025 that could compete globally.

    Original Description:

    Chinese Biopharma market is set to grow exponentially with the strong support of the Chinese govt.

    Original Title

    CHINESE BIOPHARMA-MCKINSEY REPORT

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document discusses the rise of China's biopharmaceutical industry. It notes that China now has over 4,000 biopharma companies and produces over 200 biologics. However, China still lags Western countries in terms of innovation. The government is investing heavily in R&D and talent to try to close this gap and become a global biopharma leader. The future of China's industry remains uncertain but it aims to have at least 5 homegrown biologics approved by 2025 that could compete globally.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    17 views18 pages

    Chinese Biopharma-Mckinsey Report

    Uploaded by

    PHILCARE PHARMA
    The document discusses the rise of China's biopharmaceutical industry. It notes that China now has over 4,000 biopharma companies and produces over 200 biologics. However, China still lags Western countries in terms of innovation. The government is investing heavily in R&D and talent to try to close this gap and become a global biopharma leader. The future of China's industry remains uncertain but it aims to have at least 5 homegrown biologics approved by 2025 that could compete globally.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 18

    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    1 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    2 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    3 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    4 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    5 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    6 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    7 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    8 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    9 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    10 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    11 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    12 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    13 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    14 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    15 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    16 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    17 of 18 9/9/2022, 2:57 PM
    The dawn of China biopharma innovation | McKinsey https://www.mckinsey.com/industries/life-sciences/our-insights/the-daw...

    18 of 18 9/9/2022, 2:57 PM

    You might also like